I will begin by examining the core framework files and reference materials to provide a specific and evidence-based review of the PRISM v2.1 architecture.
This review evaluates the **PRISM v2.1 framework** as a distillation engine for a small (0.8B) medical LLM. The framework is architecturally sophisticated, prioritizing **mechanistic depth** over pattern matching, which is the correct strategy for preventing "stochastic parroting" in sub-billion parameter models.

### 1. Medical Accuracy Audit
*   **Longevity-Optimal Ranges:** The ranges for **ApoB (<60 mg/dL)** and **ALT (<20 U/L)** are aggressive but defensible within the "optimization" context (Sniderman et al., *JAMA Cardiology*). However, the **Fasting Insulin <5 mIU/L** target is borderline problematic. While low insulin is a longevity goal, a 0.8B model might interpret `4.8` as "perfect" and `5.2` as "failing," missing the context of glucose levels (HOMA-IR is the better metric, which you correctly prioritize).
*   **Drug Mechanisms:** The **SGLT2i "Immunosenolysis"** mechanism (referencing *Nature Aging 2025*) is a highly specific and recent claim. If the distilled model learns this as "SGLT2i are senolytics," it may over-recommend them in non-diabetic populations without mentioning the primary hemodynamic and metabolic benefits. 
*   **Oversimplification:** The **Metformin/Complex I** explanation is accurate, but the framework omits the **Lactate/B12** trade-offs in the "Standard interpretation" step. A 0.8B model needs to be taught that Metformin is not a "free lunch" (Konopka 2019 interaction with exercise).

### 2. Missing Clinical Domains
The framework is heavily weighted toward **outpatient metabolic/preventive medicine**. To be a robust medical reasoning engine, v3 must add:
*   **Infectious Disease (ID) Stewardship:** Reasoning for antibiotic selection (spectrum of activity, local resistance, source control). Currently, ID is almost entirely absent.
*   **Toxicology/Overdose:** Specific reasoning chains for toxidromes (anticholinergic, sympathomimetic, opioid).
*   **Social Determinants & Compliance:** A "Step 7: Pragmatic Barriers" is needed. Reasoning that recommends $1,000/month GLP-1s to a patient with food insecurity is medically "accurate" but clinically "useless."
*   **Basic Procedures:** Reasoning for *when* to perform an LP, paracentesis, or intubation based on clinical triggers (e.g., "GCS <8 → protect airway").

### 3. Structural Improvements
*   **Dynamic Depth:** The 6-step structure is too heavy for simple questions (e.g., "What is the mechanism of action of Lisinopril?"). v3 should implement a **"Reasoning Complexity Tier"**:
    *   **Tier 1 (Recall):** Steps 1, 5, 6 only.
    *   **Tier 2 (Logic):** Steps 1, 3, 4, 5, 6.
    *   **Tier 3 (Complex Differential):** Full 6 steps.
*   **Step 3 (Discriminating Analysis) is the "Secret Sauce":** This is where the 0.8B model will learn the most. You should enforce a **"Mechanistic Discriminator"**—requiring the model to explain the *physiological* reason why Test A distinguishes Dx1 from Dx2.

### 4. Tool Use for Medical AI (v3 Integration)
A 0.8B model will struggle with multi-digit math. Tool use is mandatory.
*   **Format:** Integrate tool calls within **Step 4 (Lab Interpretation)** using a `<thought> → <call> → <observation>` loop.
*   **Key Tools:**
    *   **Calculator:** ASCVD 10-yr/lifetime risk, MELD-Na, Wells, HOMA-IR (don't let the model do the math).
    *   **DDI Engine:** A tool to check for CYP3A4/2D6 interactions before Step 6.
    *   **Guideline RAG:** Retrieval of the latest Tier A "Standard of Care."

### 5. Distillation Optimization for 0.8B Model
*   **Token Budget:** PRISM v2.1 generates ~800-1200 tokens per example. For a 0.8B model, this is "heavy." You should **compress the Problem Representation** (Step 1) into a single dense string to save context for the Differential and Analysis.
*   **Negative Constraints:** 0.8B models are prone to "hallucinating" certainty. The **Step 5: Confidence Score** must be trained with "LOW" confidence examples where the model explains *why* the data is insufficient.
*   **Diversity:** You need a 40/30/30 split: 40% Common Presentations, 30% Critical/Acute, 30% Longevity/Optimization. Current bias is ~70% Longevity.

### 6. Longevity Bias Assessment
The "Longevity Note" in the response format is excellent for separation. However, the **Default Route** (Step 0) should be renamed to **"Adult Chronic/Preventive"**. The model must be explicitly taught that longevity optimization is **secondary** to resolving the chief complaint. If a patient has a "Standard" LDL of 110 but is in active DKA, the model *must not* discuss ApoB targets until the Convergence (Step 5).

### 7. v3 Concrete Recommendations (Ranked by Impact)

1.  **Mechanistic "WHY" Constraint:** In Step 3, force the model to trace the signal from the molecular level to the clinical finding (e.g., "Troponin rises because [Mechanism], not just 'it is high in MI'").
2.  **Explicit Acute/Longevity Firewall:** If Route = ACUTE, the model is **prohibited** from using the Longevity-Optimal table. This prevents dangerous distractions during "stabilization" reasoning.
3.  **Tool-Calling Tokens:** Introduce `<CALC>`, `<DB_LOOKUP>`, and `<GUIDE_REF>` tokens into the CoT.
4.  **Pharmacogenomics (PGx) Gate:** Add a mandatory check in Step 6 for drugs with high-impact PGx (e.g., "Check SLCO1B1 before prescribing 80mg Simvastatin").
5.  **Pediatric/Pregnancy Logic Blocks:** Instead of just "routing," provide 5-10 specific logic rules for these (e.g., "Neonatal jaundice → check rate of rise, not just absolute value").
6.  **"Must-Not-Miss" Probability Weighting:** Force the model to explain why a "Must-Not-Miss" (e.g., Aortic Dissection) is being ruled out in Step 3.
7.  **Pre-Analytical "Noise" Step:** In Step 4, the model must check for Biotin, Fasting, and Time-of-Day before interpreting any hormone or troponin.
8.  **Hierarchical Evidence Tagging:** Ensure Tier A (Standard) and Tier C (Experimental) are visually distinct (e.g., using different markdown headers).
9.  **Trajectory Analysis Rule:** Enforce that if two timepoints are provided, the reasoning *must* calculate the **slope** (rate of change) as the primary discriminator.
10. **The "Wait" Protocol:** Teach the model to say "I need [X] data before I can conclude [Y]" for cases with ambiguous stems, rather than guessing.
